Join us   Log in  

PHARMASPIRE - Volume 14,Issue 2, 2022 , April-June

Pages: 85-89
Print Article   Download XML  Download PDF

Substantiating the mechanism of Boswellic acids through molecular docking study

Author: Chandrakant Sahu, Pooja A. Chawla

Category: P'Ceutical Chemistry


Inflammation is the first response shown by the immune system in defense to any attack by bacteria or viruses. Inflammation is responsible for contributing to half of the world’s global burden of disease. It is mainly characterized by pain (dolor), heat (calor), swelling (tumor), and redness (rubor). The inflammatory cascades are the sole reasons for many musculoskeletal disorders. These musculoskeletal disorders are prevalent throughout the world, with a ubiquitous impact leading to long-term pain and disability. They significantly affect the psychosocial status of people who have them. Boswellic acids (BA), a natural mixture isolated from oleo gum resin of Boswellia serrata comprised of four major pentacyclic triterpene acids: Beta-BA, 3-acteyl beta BA, 11-keto-beta-BA, and 3-acetyl-11-keto-beta-BA, isolated from the oleo gum resin of B. serrata is reported to be effective as anti-inflammatory, immunomodulatory, anti-tumor, anti-asthmatic and in chronic colitis. Its anti-inflammatory activity has been attributed to the inhibition of 5-lipoxygenase in a selective, enzyme-linked non-redox, and non-competitive manner. The anti-asthmatic reports on BA revealed that leukotriene and elastase enzyme inhibition might be responsible for this effect. Although BA acts through several mechanisms for its biological activities, the inhibition of leukotrienes is the primary and the most scientifically proved mechanism. This work substantiates the effect of B. serrata BAs through molecular docking study into the cavity of 5-LOX enzyme.

Keywords: Boswellic acid, Boswellia serrata, anti-inflammatory , molecular docking, 5-LOX

DOI: 10.56933/Pharmaspire.2022.14110



1. Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: An overview. Indian J Pharm Sci 2011;73:255-61.
2. Etzel R. Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis. Phytomedicine 1996;3:91-4.
3. Umar S, Umar K, Sarwar AH, Khan A, Ahmad N, Ahmad S, et al. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine 2014;21:847-56.
4. Sontakke S, Thawani V, Pimpalkhute S, Kabra P, Babhulkar S, Hingorani L. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J Pharmacol 2007;39:27-9.
5. Ammon H. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine 2010;17:862-7.
6. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata. Clin Pharmacokinet 2011;50:349-69.
7. Singh S, Khajuria A, Taneja S, Johri RK, Singh J, Qazi GN. Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine 2008;15:400-7.
8. Singh G, Singh S, Bani S. Anti-inflammatory actions of boswellic acids. Phytomedicine 1996;3:81-5.
9. Poeckel D, Werz O. Boswellic acids: Biological actions and molecular targets. Curr Med Chem 2006;13:3359-69.
10. Silva BC, de Miranda AS, Rodrigues FG, Silveira AL, Resende GH, Moraes MF, et al. The 5-lipoxygenase
(5-LOX) inhibitor zileuton reduces inflammation and infarct size with improvement in neurological outcome following cerebral ischemia. Curr Neurovasc Res 2015;12:398-403.
11. Huey R, Morris GM, Forli S. Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. The Scripps Research Institute Molecular Graphics Laboratory; 2012. p. 10550.
12. Gilbert NC, Gerstmeier J, Schexnaydre EE, Börner F, Garscha U, Neau DB, et al. Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products. Nat Chem Biol 2020;16:783-90.
13. Rauf MA, Zubair S, Azhar A. Ligand docking and binding site analysis with pymol and autodock/vina. Int J Basic Appl Sci 2015;4:168